// App-Quantinova.ai

3083 : Novel inhibitor GZ17-06.12 suppresses pancreatic cancer tumorigenesis

Researchers

Presenter

  • Santanu Paul

Principal Investigators

  • Lisa Stehno-Bittel

  • Animesh Dhar

Medical Centers

  • University of Kansas Medical Center, Kansas City, MO

  • LIKARDA INC, University of Kansas Medical Center, Kansas City, KS.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Lung Cancer

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved